Difficulty: Medium
Average Score: 73%
Practice
Poor prognostic factors in Hodgkin lymphoma include all the following EXCEPT
Correct answer
A
Rationale
In Hodgkin lymphoma, poor prognostic factors indicate a higher likelihood of treatment failure or disease progression. The correct answer, A) age of more than 15 years at the time of diagnosis, is not considered a poor prognostic factor. In fact, younger age is generally associated with better outcomes in Hodgkin lymphoma due to the more favorable biology of the disease in this age group.
Option B) stage IV disease is a poor prognostic factor as it signifies more extensive disease spread and a higher tumor burden, leading to a worse prognosis. Option C) manifested by positron emission tomography (PET) scan positivity is also a poor prognostic factor, as it indicates more aggressive disease behavior.
Option D) poor response to therapy is an obvious poor prognostic factor as it suggests that the disease is not responding adequately to treatment, leading to a worse outcome. Understanding these poor prognostic factors is crucial for clinicians in determining the appropriate treatment approach and predicting patient outcomes in Hodgkin lymphoma.
Educationally, this question highlights the importance of recognizing poor prognostic factors in Hodgkin lymphoma to guide clinical decision-making and prognosis assessment. It reinforces the significance of age, disease stage, imaging findings, and treatment response in predicting outcomes in pediatric patients with Hodgkin lymphoma.
Option B) stage IV disease is a poor prognostic factor as it signifies more extensive disease spread and a higher tumor burden, leading to a worse prognosis. Option C) manifested by positron emission tomography (PET) scan positivity is also a poor prognostic factor, as it indicates more aggressive disease behavior.
Option D) poor response to therapy is an obvious poor prognostic factor as it suggests that the disease is not responding adequately to treatment, leading to a worse outcome. Understanding these poor prognostic factors is crucial for clinicians in determining the appropriate treatment approach and predicting patient outcomes in Hodgkin lymphoma.
Educationally, this question highlights the importance of recognizing poor prognostic factors in Hodgkin lymphoma to guide clinical decision-making and prognosis assessment. It reinforces the significance of age, disease stage, imaging findings, and treatment response in predicting outcomes in pediatric patients with Hodgkin lymphoma.